View Cart  

Threshold Pharma Cancer Trial Result Spooks Investors

A A
An experimental pancreatic cancer treatment from Threshold Pharmaceuticals failed to show statistically significant improvement in overall survival, spooking investors and sending its shares down as much as a third.
Reuters